EP 2099490 A1 20090916 - NEW DRUG FOR INHIBITING, PREVENTING OR TREATMENT OF RHEUMATOID ARTHRITIS
Title (en)
NEW DRUG FOR INHIBITING, PREVENTING OR TREATMENT OF RHEUMATOID ARTHRITIS
Title (de)
NEUES ARZNEIMITTEL ZUR UNTERDRÜCKUNG, VERHINDERUNG ODER BEHANDLUNG VON RHEUMATOIDER ARTHRITIS
Title (fr)
NOUVEAU MÉDICAMENT DESTINÉ À L'INHIBITION, LA PRÉVENTION OU LE TRAITEMENT DE LA POLYARTHRITE RHUMATOÏDE
Publication
Application
Priority
- FR 2007052409 W 20071128
- FR 0655194 A 20061129
Abstract (en)
[origin: WO2008065304A1] The present invention pertains to the use of at least one interleukin 17F inhibitor and/or at least one TIL17 receptor inhibitor, for the preparation of a drug for the inhibition, the prevention or the treatment of rheumatoid arthritis. The invention also relates to a pharmaceutical composition comprising, as active ingredient, at least one interleukine 17F inhibitor and/or at least one TIL17 receptor inhibitor in association with an adequate pharmaceutical carrier, as well as its use for the inhibition, the prevention or the treatment of rheumatoid arthritis.
IPC 8 full level
A61K 31/7088 (2006.01); A61K 31/7105 (2006.01); A61K 39/395 (2006.01); C07K 14/715 (2006.01); C07K 16/28 (2006.01)
CPC (source: EP US)
A61K 39/3955 (2013.01 - EP US); A61P 19/02 (2017.12 - EP); C07K 14/54 (2013.01 - EP US); C07K 14/715 (2013.01 - EP US); C07K 16/2866 (2013.01 - EP US); C12N 15/1138 (2013.01 - EP US); A61K 2039/505 (2013.01 - EP US); A61K 2039/507 (2013.01 - EP US); C12N 2310/14 (2013.01 - EP US)
Citation (search report)
See references of WO 2008065304A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
FR 2908999 A1 20080530; FR 2908999 B1 20120427; EP 2099490 A1 20090916; US 2010021456 A1 20100128; WO 2008065304 A1 20080605
DOCDB simple family (application)
FR 0655194 A 20061129; EP 07858747 A 20071128; FR 2007052409 W 20071128; US 31237507 A 20071128